Literature DB >> 16061892

Methods to estimate the optimal threshold for normally or log-normally distributed biological tests.

Jérôme Jund1, Muriel Rabilloud, Martine Wallon, René Ecochard.   

Abstract

Putting a screening or a diagnostic test into everyday use requires the determination of its threshold. The authors present methods that yield a point and an interval estimation of the threshold that maximize the population utility whenever the test results are normally or log-normally distributed among healthy and among diseased subjects, with equal variances. These methods were assessed for bias, coverage probability, coverage symmetry, and confidence-interval width using simulation. They proved to be asymptotically nonbiased and to have a satisfactory coverage probability whenever the sample sizes of the healthy and the diseased subjects are equal to or greater than 50. The methods were next applied to determine an optimal threshold for the antibody load used to diagnose congenital toxoplasmosis at birth. The methods are easy to implement and impose few constraints; however, the sample sizes should be carefully determined according to the required accuracy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16061892     DOI: 10.1177/0272989X05276855

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  6 in total

1.  Clinically significant differences in acute pain measured on self-report pain scales in children.

Authors:  Daniel S Tsze; Gerrit Hirschfeld; Carl L von Baeyer; Blake Bulloch; Peter S Dayan
Journal:  Acad Emerg Med       Date:  2015-03-13       Impact factor: 3.451

2.  Performance metric curve analysis framework to assess impact of the decision variable threshold, disease prevalence, and dataset variability in two-class classification.

Authors:  Heather M Whitney; Karen Drukker; Maryellen L Giger
Journal:  J Med Imaging (Bellingham)       Date:  2022-05-31

3.  Optimal cut-point definition in biomarkers: the case of censored failure time outcome.

Authors:  Matteo Rota; Laura Antolini; Maria Grazia Valsecchi
Journal:  BMC Med Res Methodol       Date:  2015-03-21       Impact factor: 4.615

4.  Estimating the optimal threshold for a diagnostic biomarker in case of complex biomarker distributions.

Authors:  Fabien Subtil; Muriel Rabilloud
Journal:  BMC Med Inform Decis Mak       Date:  2014-06-14       Impact factor: 2.796

5.  The optimal threshold of serum ceruloplasmin in the diagnosis of Wilson's disease: A large hospital-based study.

Authors:  Rong Xu; Yong-Fang Jiang; Yong-Hong Zhang; Xu Yang
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

6.  Why the C-statistic is not informative to evaluate early warning scores and what metrics to use.

Authors:  Santiago Romero-Brufau; Jeanne M Huddleston; Gabriel J Escobar; Mark Liebow
Journal:  Crit Care       Date:  2015-08-13       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.